GSK3B and renal carcinoma: In addition, Western blot showed that the expression of MMP-2, MMP-9, c-myc, and β-catenin was decreased, while the expression of GSK-3β was increased in A498 and 769-P renal cancer cells after interfering with UHRF1 expression.